The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Size Of The Sexually Transmitted Disease (STD) Self-Testing Market In 2026 And How Much Will It Reach By 2030?
The sexually transmitted disease (std) self-testing market has demonstrated significant expansion in recent years. Its valuation is anticipated to climb from $1.52 billion in 2025 to $1.67 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. The primary drivers for this historical increase include insufficient public understanding of std testing, the social stigma associated with attending clinics, an over-reliance on hospital-based testing, a scarcity of convenient testing options, and the increasing occurrence of sexually transmitted diseases.
The sexually transmitted disease (std) self-testing market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $2.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This anticipated growth is driven by several factors, including the increasing use of digital health platforms, the introduction of multi-sample at-home testing kits, enhanced government initiatives for awareness, a rise in telehealth consultations, and advancements in rapid and precise diagnostic technologies. Key trends expected during this period involve a surge in demand for at-home std testing kits, greater public consciousness regarding sexual health and the benefits of early diagnosis, the expansion of telehealth and remote consultation services, the widening of online and retail pharmacy distribution networks, and the incorporation of multi-sample testing solutions (covering blood, urine, and oral samples).
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp
What Important Drivers Are Powering The Sexually Transmitted Disease (STD) Self-Testing Market Growth?
The increasing occurrence of syphilis is projected to drive expansion within the sexually transmitted disease (STD) self-testing market. Syphilis, a sexually transmitted infection, manifests as bodily sores and can result in severe health issues without proper treatment. The rise in syphilis cases stems from a decrease in regular condom usage, especially among individuals involved in high-risk sexual activities. STD self-testing offers a discreet and convenient way to screen for syphilis at home, facilitating prompt diagnosis. Such early detection leads to timely treatment, thereby reducing complications and inhibiting broader transmission. As an illustration, in September 2025, the Centers for Disease Control and Prevention, a US-based government agency, indicated approximately 209,253 syphilis cases were reported in 2023, marking a 1% increase from 207,269 cases in 2022. Consequently, the escalating number of syphilis cases is fueling the growth of the sexually transmitted disease (STD) self-testing market.
Which Segment Groups Define The Sexually Transmitted Disease (STD) Self-Testing Market Landscape?
The sexually transmitted disease (std) self-testing market covered in this report is segmented –
1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications
Subsegments:
1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device
2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection
3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection
What Trends Are Influencing The Sexually Transmitted Disease (STD) Self-Testing Market?
Leading companies within the STD self-testing market are concentrating on developing advanced products, such as over-the-counter (OTC) sample collection kits, to encourage early detection and timely treatment of infections. Over-the-counter sample collection kits function as at-home diagnostic tools, enabling individuals to gather samples like urine or swabs without requiring a prescription. They offer a convenient and confidential method for detecting infections early and facilitating prompt treatment. For instance, in August 2023, iHealth Labs Inc., a US-based digital health company, introduced the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit permits individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the comfort and privacy of their own home. Users can dispatch their samples to the lab using a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit delivers highly accurate results, featuring sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples are processed in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with strict federal and state quality standards through regular inspections.
Which Firms Are Competing In The Sexually Transmitted Disease (STD) Self-Testing Market?
Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.
Access The Complete Sexually Transmitted Disease (STD) Self-Testing Market Report:
Which Region Holds The Largest Share In The Sexually Transmitted Disease (STD) Self-Testing Market?
North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Sexually Transmitted Disease (STD) Self-Testing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp
Browse Through More Reports Similar to the Global Sexually Transmitted Disease (STD) Self-Testing Market 2026, By The Business Research Company
Std Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report
Sexually Transmitted Infections Stis Market Report 2026
Chlamydia Trachomatis Ct And Neisseria Gonorrhoeae Ng Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model